Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Spinal Anaesthesia: Hyperbaric 2.2ml Levobupivacaine
Control Intervention1: Intrathecal Dexmedetomidine: Intrathecally Dexmedetomidine will be given to
Group A - dexmedetomidine 5mcg.
Sponsors
Sri Guru Ram Das Institute of Medical Sciences and Research
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA Physical status I - II 2.Patients undergoing Transurethral resection of prostate, Ureteroscopic lithotripsy,Cystoscopy, Other urological procedures under spinal anaesthesia.
Exclusion criteria
Exclusion criteria: 1.Known hypersensitivity to study drugs. 2.History of coagulopathy 3.Skin infection at spinal site 4.Spine deformity 5.Major Co-morbidities (hepatic, renal and cardiovascular) 6.Pregnant female
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the duration of post operative analgesia by three different doses of dexmedetomidine when used as adjuvant to low dose hyperbaric levobupivacaine in spinal anaesthesia using VAS ScoreTimepoint: from completion of surgery till 12 hours postoperative | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To measure time to first request and total number of rescue analgesia postsurgery in first 12 hours in each group. 2.To investigate the incidence of adverse effects. - Bradycardia - Hypotension - Post operative nausea /vomiting - Respiratory depression - sedation Timepoint: from completion of surgery till 12 hours postoperative | — |
Countries
India
Contacts
Public ContactDr Jobanjeet Kaur Hundal
Sri Guru Ram Das Institute of Medical Sciences and Research
Outcome results
None listed